Used as a key intermediate in the synthesis of pharmaceutical agents, particularly in the development of kinase inhibitors for cancer treatment. It serves as a building block in the preparation of active pharmaceutical ingredients (APIs) targeting inflammatory diseases and neurological disorders. Its structure allows for selective modification, enabling optimization of drug potency and metabolic stability. Commonly employed in research and development within medicinal chemistry for designing small molecule therapeutics.